Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,815,631
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
19,642,118
-
Shares change
-
+11,938,800
-
Total reported value, excl. options
-
$199,571,620
-
Value change
-
+$124,369,380
-
Put/Call ratio
-
24%
-
Number of buys
-
48
-
Number of sells
-
-10
-
Price
-
$10.16
Significant Holders of EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT) as of Q1 2021
70 filings reported holding EYPT - EyePoint Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
EyePoint Pharmaceuticals, Inc. - Common Stock (EYPT) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,642,118 shares
of 82,815,631 outstanding shares and own 23.72% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4,190,921 shares), FRANKLIN RESOURCES INC (2,888,247 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,518,211 shares), RA CAPITAL MANAGEMENT, L.P. (1,250,000 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1,181,200 shares), CITADEL ADVISORS LLC (1,035,604 shares), VANGUARD GROUP INC (904,439 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (810,816 shares), VR Adviser, LLC (700,000 shares), and JANUS HENDERSON GROUP PLC (673,385 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.